Recent Advances in Molecular Biology of Thyroid Cancer and Their Clinical Implications
- 31 December 2008
- journal article
- review article
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 41 (6) , 1135-1146
- https://doi.org/10.1016/j.otc.2008.07.001
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Functional Characterization of the T1799-1801del and G1799-1816ins BRAF Mutations in Papillary Thyroid CancerCell Cycle, 2007
- RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize LectureActa Endocrinologica, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Mutation of the PIK3CA oncogene in human cancersBritish Journal of Cancer, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancerClinical Endocrinology, 2005
- Genetic Alterations and Aberrant Expression of Genes Related to the Phosphatidyl‐lnositol‐3′‐Kinase/Protein Kinase B (Akt) Signal Transduction Pathway in GlioblastomasBrain Pathology, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002
- The block of thyroglobulin synthesis, which occurs upon transformation of rat thyroid epithelial cells, is at the transcriptional level and it is associated with methylation of the 5′ flanking region of the geneExperimental Cell Research, 1989